2254. Multicenter Evaluation of Ceftazidime–Avibactam for Multidrug-Resistant Pseudomonas aeruginosa Infections

BACKGROUND: Ceftazidime–avibactam (CZA) is a novel cephalosporin/β-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae (CRE) and multidrug-resistant (MDR) Pseudomonas aeruginosa (PA). Real-world experience with CZA for CRE infections is accumulating but data on its use...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorgensen, Sarah C J, Trinh, Trang D, Zasowski, Evan J, Alosaimy, Sara, Lagnf, Abdalhamid M, Bhatia, Sahil, Melvin, Sarah, Simon, Samuel, Steed, Molly E, Rosenberg, Joshua R, Estrada, Sandra J, Davis, Susan L, Rybak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809679/
http://dx.doi.org/10.1093/ofid/ofz360.1932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809679/
http://dx.doi.org/10.1093/ofid/ofz360.1932

Ejemplares similares